November 1, 2020
Briefings on APCs

Debbie Jones, CPC, CCA, details ICD-10-CM coding for strabismus and CPT coding for surgical treatments used to correct eye misalignment.

November 1, 2020
Briefings on APCs

Valerie A. Rinkle, MPA, CHRI, writes about Medicare guidance on and updated payment policies for COVID-19 testing, vaccines, and telehealth services.

October 1, 2020
Briefings on APCs

Outpatient coders should be familiar with CPT reporting for knee surgeries based on information in the operative note. This article reviews the anatomy of the knee joint and CPT coding for arthroscopic and reconstructive procedures used to visualize and treat common knee conditions.

October 1, 2020
Briefings on APCs

The final 2021 CPT, ICD-10-CM, and ICD-10-PCS code sets were released in September, introducing new, revised, and deleted codes for diagnostic and procedural services and accompanying guideline changes.

October 1, 2020
Briefings on APCs

Valerie A. Rinkle, MPA, CHRI, reviews what providers need to know about the latest payment model from CMS’ Centers for Medicare and Medicaid Innovation.

September 15, 2020
Briefings on APCs

CMS continues to focus on site-neutral payment policies and keeping payments down for 340B-acquired drugs in the 2021 OPPS proposed rule, released in early August.

September 1, 2020
Briefings on APCs

Several recent changes affect hospitals’ 340B programs. Follow these eight tips to review and optimize your hospital’s 340B program.

August 1, 2020
Briefings on APCs

In response to the novel coronavirus (COVID-19) public health emergency, CMS has expanded patient access to telehealth services, allowing beneficiaries to receive a wide range of services without having to visit a healthcare facility.

August 1, 2020
Briefings on APCs

Judith L. Kares, JD, writes about the unique coverage, billing, and payment rules that apply to these blood products and related services under Part B.

August 4, 2020
News & Insights

Facing the unprecedented COVID-19 public health emergency, CMS released the 2021 OPPS proposed rule later than ever before, with the agency generally reinforcing its recent focus on site-neutral payment policies, lowering reimbursement for drugs purchased under the 340B program, and adding more services to the list of prior authorization. 

Pages